Abstract
To assess the dynamics of pain syndrome in patients receiving Dolocox for nonspecific back pain (NBS) in routine outpatient practice, the safety of treatment and satisfaction with its results of the doctor and patient. The study included 70 patients who received standard therapy for NBS for 14 days. On days 1, 10 and 14, the effects were evaluated using a visual analog pain scale, the Rolland-Maurice scale, FTF test, clinical impression scales and subjective evaluation of the effectiveness of therapy. The results of the study demonstrated comparable indicators of the dynamics of pain syndrome, the level of pain intensity reduction, the tolerability of treatment, as well as a subjective assessment of the effectiveness of therapy on the 10th and 14th day of therapy. There were no serious adverse events during treatment. The results obtained allow us to recommend short-term use of Dolocox to reduce the risk of potential side effects and increase adherence to therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
